Related references
Note: Only part of the references are listed.Recent advances in RASopathies
Yoko Aoki et al.
JOURNAL OF HUMAN GENETICS (2016)
Phosphoinositide 3-Kinase-C2α Regulates Polycystin-2 Ciliary Entry and Protects against Kidney Cyst Formation
Irene Franco et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
Somatic overgrowth disorders of the PI3K/AKT/mTOR pathway & therapeutic strategies
Kim M. Keppler-Noreuil et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART C-SEMINARS IN MEDICAL GENETICS (2016)
Somatic activating mutations in Pik3ca cause sporadic venous malformations in mice and humans
Sandra D. Castillo et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Somatic PIK3CA mutations as a driver of sporadic venous malformations
Pau Castel et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
mTORC1-mediated inhibition of polycystin-1 expression drives renal cyst formation in tuberous sclerosis complex
Monika Pema et al.
NATURE COMMUNICATIONS (2016)
A four-gene signature predicts survival in clear-cell renal-cell carcinoma
Jun Dai et al.
ONCOTARGET (2016)
New insights into the generation and role of de novo mutations in health and disease
Rocio Acuna-Hidalgo et al.
GENOME BIOLOGY (2016)
Heterozygous expression of the oncogenic Pik3caH1047R mutation during murine development results in fatal embryonic and extraembryonic defects
Lauren M. Hare et al.
DEVELOPMENTAL BIOLOGY (2015)
Sirolimus for the treatment of children with various complicated vascular anomalies
Herwig Lackner et al.
EUROPEAN JOURNAL OF PEDIATRICS (2015)
Ubiquitous expression of the Pik3caH1047R mutation promotes hypoglycemia, hypoinsulinemia, and organomegaly
Kathryn M. Kinross et al.
FASEB JOURNAL (2015)
PI3K-C2α: One enzyme for two products coupling vesicle trafficking and signal transduction
Carlo C. Campa et al.
FEBS LETTERS (2015)
Rapamycin as Novel Treatment for Refractory-to-Standard-Care Slow-Flow Vascular Malformations
Laurence M. Boon et al.
PLASTIC AND RECONSTRUCTIVE SURGERY (2015)
Molecular and Functional Characterization of Three Different Postzygotic Mutations in PIK3CA-Related Overgrowth Spectrum (PROS) Patients: Effects on PI3K/AKT/mTOR Signaling and Sensitivity to PIK3 Inhibitors
Daria C. Loconte et al.
PLOS ONE (2015)
Cell type of origin as well as genetic alterations contribute to breast cancer phenotypes
Divya Bhagirath et al.
ONCOTARGET (2015)
Inactivation of the Class II PI3K-C2β Potentiates Insulin Signaling and Sensitivity
Samira Alliouachene et al.
CELL REPORTS (2015)
PIK3CA-Related Overgrowth Spectrum (PROS): Diagnostic and Testing Eligibility Criteria, Differential Diagnosis, and Evaluation
Kim M. Keppler-Noreuil et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2015)
How PI3K-derived lipids control cell division
Carlo C. Campa et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2015)
Neurocutaneous Manifestations of Genetic Mosaicism
Maurice A. M. van Steensel
JOURNAL OF PEDIATRIC GENETICS (2015)
Overgrowth Syndromes
Andrew C. Edmondson et al.
JOURNAL OF PEDIATRIC GENETICS (2015)
Clinical delineation and natural history of the PIK3CA-related overgrowth spectrum
Kim M. Keppler-Noreuil et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2014)
PI3K/AKT signaling pathway and cancer: an updated review
Miriam Martini et al.
ANNALS OF MEDICINE (2014)
PI3K Class II α Controls Spatially Restricted Endosomal PtdIns3P and Rab11 Activation to Promote Primary Cilium Function
Irene Franco et al.
DEVELOPMENTAL CELL (2014)
PIK3CA Activating Mutations in Facial Infiltrating Lipomatosis
Reid A. Maclellan et al.
PLASTIC AND RECONSTRUCTIVE SURGERY (2014)
Sirolimus treatment of severe PTEN hamartoma tumor syndrome: case report and in vitro studies
Gordian L. Schmid et al.
PEDIATRIC RESEARCH (2014)
Somatic gain-of-function mutations in PIK3CA in patients with macrodactyly
Jonathan J. Rios et al.
HUMAN MOLECULAR GENETICS (2013)
Rapalogs and mTOR inhibitors as anti-aging therapeutics
Dudley W. Lamming et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
High cumulative risks of cancer in patients with PTEN hamartoma tumour syndrome
Virginie Bubien et al.
JOURNAL OF MEDICAL GENETICS (2013)
Loss of cilia suppresses cyst growth in genetic models of autosomal dominant polycystic kidney disease
Ming Ma et al.
NATURE GENETICS (2013)
Somatic Mosaic Activating Mutations in PIK3CA Cause CLOVES Syndrome
Kyle C. Kurek et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2012)
Regulation and cellular functions of class II phosphoinositide 3-kinases
Marco Falasca et al.
BIOCHEMICAL JOURNAL (2012)
Mosaic overgrowth with fibroadipose hyperplasia is caused by somatic activating mutations in PIK3CA
Marjorie J. Lindhurst et al.
NATURE GENETICS (2012)
De novo germline and postzygotic mutations in AKT3, PIK3R2 and PIK3CA cause a spectrum of related megalencephaly syndromes
Jean-Baptiste Riviere et al.
NATURE GENETICS (2012)
De novo somatic mutations in components of the PI3K-AKT3-mTOR pathway cause hemimegalencephaly
Jeong Ho Lee et al.
NATURE GENETICS (2012)
Oncogenic mutations mimic and enhance dynamic events in the natural activation of phosphoinositide 3-kinase p110α (PIK3CA)
John E. Burke et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Genomic determinants of P13K pathway inhibitor response in cancer
Britta Weigelt et al.
FRONTIERS IN ONCOLOGY (2012)
Cystogenesis and elongated primary cilia in Tsc1-deficient distal convoluted tubules
Eric A. Armour et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2012)
Luminal Expression of PIK3CA Mutant H1047R in the Mammary Gland Induces Heterogeneous Tumors
Dominique S. Meyer et al.
CANCER RESEARCH (2011)
Stenting versus Aggressive Medical Therapy for Intracranial Arterial Stenosis
Marc I. Chimowitz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Mechanisms of Disease: Ciliopathies
Friedhelm Hildebrandt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
An Activating Mutation of AKT2 and Human Hypoglycemia
K. Hussain et al.
SCIENCE (2011)
Prospects for mTOR Inhibitor Use in Patients with Polycystic Kidney Disease and Hamartomatous Diseases
Vicente E. Torres et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
The emerging mechanisms of isoform-specific PI3K signalling
Bart Vanhaesebroeck et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2010)
Sirolimus and Kidney Growth in Autosomal Dominant Polycystic Kidney Disease
Andreas L. Serra et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Everolimus in Patients with Autosomal Dominant Polycystic Kidney Disease
Gerd Walz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Polycystic Kidney Disease
Peter C. Harris et al.
ANNUAL REVIEW OF MEDICINE (2009)
Characterization of a distinct syndrome that associates complex truncal overgrowth, vascular, and acral anomalies: a descriptive study of 18 cases of CLOVES syndrome
Ahmad I. Alomari
CLINICAL DYSMORPHOLOGY (2009)
Loss of Tsc1, but not Pten, in renal tubular cells causes polycystic kidney disease by activating mTORC1
Jing Zhou et al.
HUMAN MOLECULAR GENETICS (2009)
The Absence of BRAF, FGFR3, and PIK3CA Mutations Differentiates Lentigo Simplex from Melanocytic Nevus and Solar Lentigo
Christian Hafner et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2009)
Effects of oncogenic p110α subunit mutations on the lipid kinase activity of phosphoinositide 3-kinase
Jeffrey D. Carson et al.
BIOCHEMICAL JOURNAL (2008)
pVHL and PTEN tumour suppressor proteins cooperatively suppress kidney cyst formation
Ian J. Frew et al.
EMBO JOURNAL (2008)
Cyst formation and activation of the extracellular regulated kinase pathway after kidney specific inactivation of Pkd1
Sekiya Shibazaki et al.
HUMAN MOLECULAR GENETICS (2008)
Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity
Sauveur-Michel Maira et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers
Jeffrey A. Engelman et al.
NATURE MEDICINE (2008)
An efficient and versatile system for acute and chronic modulation of renal tubular function in transgenic mice
Milena Traykova-Brauch et al.
NATURE MEDICINE (2008)
Rapamycin treatment for a child with germline PTEN mutation
Deborah J. Marsh et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2008)
Newly delineated syndrome of congenital lipomatous overgrowth, vascular malformations, and epidermal nevi (CLOVE syndrome) in seven patients
Julie C. Sapp et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2007)
Oncogenic PIK3CA mutations occur in epidermal nevi and seborrheic keratoses with a mutation pattern
Christian Hafner et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Segmental overgrowth, lipomatosis, arteriovenous malformation and epidermal nevus (SOLAMEN) syndrome is related to mosaic PTEN nullizygosity
Frederic Caux et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2007)
pVHL and GSK3β are components of a primary cilium-maintenance signalling network
Claudio R. Thoma et al.
NATURE CELL BIOLOGY (2007)
Rare cancer-specific mutations in PIK3CA show gain of function
Marco Gymnopoulos et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
The tuberous sclerosis complex
Peter B. Crino et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Rapamycin delays but does not prevent recovery from acute renal failure: Role of acquired tubular resistance
Wilfred Lieberthal et al.
TRANSPLANTATION (2006)
Mutations of PIK3CA are rare in cutaneous melanoma
K Omholt et al.
MELANOMA RESEARCH (2006)
High frequency of coexistent mutations of PIK3CA and PTEN genes in endometrial carcinoma
K Oda et al.
CANCER RESEARCH (2005)
Rapamycin markedly slows disease progression in a rat model of polycystic kidney disease
YX Tao et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Oncogenic mutations of PIK3CA in human cancers
Y Samuels et al.
CELL CYCLE (2004)
Genetics and pathogenesis of polycystic kidney disease
P Igarashi et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2002)
The phosphatidylinositol 3-kinase-AKT pathway in human cancer
I Vivanco et al.
NATURE REVIEWS CANCER (2002)
Share Paper
